FDA Proposes Informed Consent Waivers for Low-Risk Trials

Drug Industry Daily
A A
Researchers in low-risk clinical trials could experiment on patients without obtaining informed consent if they meet at least four conditions, the FDA proposed Tuesday in a new rulemaking notice.

To View This Article:

Login

Subscribe To Drug Industry Daily